GxP Lifeline

 

  • Santa Embraces Manufacturing Excellence

    6 December, 2018 by Sarah Beale, Staff Writer, MasterControl

    When you’ve got a hard deadline, efficiency is everything and no one knows this better than Santa. While he has the entire year to prepare for December 25th, he’s also preparing up until the last second to ensure he’s got everything ready for the big day. To pull this off, he needs a reliable digital production records solution.

    Full story

  • The Importance of Knowing What You Don’t Know About Drug Development

    4 December, 2018 by Arvilla Trag, RAC, Consultant, BioProcess Technology

    New drug development is Sunday drive, especially for startups. There can be costly mistakes and unanticipated roadblocks that pop up when you least expect it. Learn how to steer clear of hazards, what to do and who to talk to.

    Full story

  • Building an Audit-Ready QMS

    15 November, 2018 by Joy McElroy, Consultant and Business Development Director, Maynard Consulting Company

    Consumers and patients assume manufactured pharmaceuticals are safe and effective. In order for quality units to assure this, you have to have a robust quality control (QC) and quality assurance (QA) program guided by an equally sound quality management system (QMS). Learn the roles of QC and QA and how to create a QMS that will help your company maintain a high level of quality.

    Full story

  • PwC Report Analyzes Health Care Policy Issues

    15 November, 2018 by PricewaterhouseCoopers Health Research Institute

    PwC’s Health Research Institute recently issued a report on the U.S. midterm election that analyzes policy issues that may well impact the American health care industry for years to come, particularly those in the pharmaceutical and life science industries. Learn what this means for manufacturers.

    Full story

  • Top 5 Nutraceutical Trends in 2018 - Conducting Clinical Trials on Nutraceuticals

    8 November, 2018 by Sarah Beale, Staff Writer, MasterControl

    Nutraceutical companies have never been required to conduct clinical trials. However, many are now voluntarily taking on this endeavor to show that their products work as advertised. This adds legitimacy to nutraceuticals and provides a better value for consumers, but the complexity of clinical trials presents a significant hurdle.

    Full story

  • Risk Management and the Human Species

    6 November, 2018 by Rai Chowdhary, CEO and Founder, The KPI System

    Science has shown that human beings are not immune from making irrational choices when it comes to risk management, even in the life sciences. This can have significant effect on manufacturing processes, and ultimately, patients. Learn how to avoid falling into this trap.

    Full story

  • Advancing the Regulatory Profession in Utah

    1 November, 2018 by Robert M. Wolfarth, Chairman, RAPS Utah Chapter

    Based on recent economic study and the establishment of the Silicon Slopes technology corridor, Utah has one of the fastest-growing life sciences communities in the U.S. Learn about the Regulatory Affairs Professionals Society’s (RAPS) new Utah Chapter and what the organization is doing to attract more regulatory affairs experts to life sciences careers.

    Full story

  • Top 5 Nutraceutical Trends in 2018 - Getting Creative With Protein

    30 October, 2018 by Sarah Beale, Staff Writer, MasterControl

    The protein supplement category is no longer exclusively for hardcore athletes. The general population is now full of people who are concerned that they’re not getting enough protein in their diets. These consumers are increasingly turning to supplements to fill the void.

    Full story

  • De Novo Becoming Faster and Easier Pathway to Market

    25 October, 2018 by David Jensen, Staff Writer, MasterControl

    There are many pathways to bring a medical device to market. The 510(k) and premarket approval (PMA) are the most common, while the de novo pathway is less popular. Advances in technology and changes in regulatory standards are making the de novo a more attractive option.

    Full story

  • What's Hiding in Your Labeling Artwork?

    23 October, 2018 by Dan Vuksanovich, Regional Sales Manager, Schlafender Hase

    Because there are potential but invisible risks inherent in labeling artwork documents of life science companies that can’t be detected through manual proofreading, it’s important to be thorough and to know the tricks to detect and prevent these snags from causing unnecessary delays in the manufacturing process.

    Full story

  • BraveHeart Team Emphasizes Quality-First Approach

    16 October, 2018 by David Jensen, Staff Writer, MasterControl

    One trap regulated startups should try to avoid is having unrealistic assumptions about what it takes to achieve compliance. Part 3 of this article series features several members of the BraveHeart team discussing their views and expectations for quality throughout the Wearable Life Sensor’s life cycle.

    Full story

  • FMEA Without Tears: A Prescription to Reduce Pain and Confusion

    11 October, 2018 by Rai Chowdhary, CEO and Founder, The KPI System

    Failure modes and effects analysis (FMEA) is a particularly effective tool in risk management. But its use is often accompanied by fear or pain because practitioners struggle to apply it. Learn how to effectively use FMEA without trepidation to improve your company’s risk management operations.

    Full story

  • Airplane Preflight Check Exemplifies Quality in Med Device Design

    10 October, 2018 by David Jensen, Staff Writer, MasterControl

    Before any aircraft leaves the ground, it undergoes a preflight check. Part 2 of this series on BraveHeart features Steve McCalmont performing an aircraft preflight check to illustrate how this critical part of flying equates to the importance of incorporating quality in the design of a medical device.

    Full story